Stocksigma LogoStocksigma Logo

Aatmaj Healthcare H1 FY27 Performance Update and Growth Strategy

Aatmaj Healthcare reported H1 FY27 revenue from operations of ₹16.96 Cr, up 56.89% YoY, while EBITDA grew 15.25% YoY to ₹2.04 Cr

Aatmaj Healthcare H1 FY27 Performance Update and Growth Strategy

Aatmaj Healthcare Ltd · Others (Uncategorized) · 01 Nov 2026, 3:30 pm

Aatmaj Healthcare H1 FY27 Performance Update and Growth Strategy Aatmaj Healthcare reported H1 FY27 revenue from operations of ₹16.96 Cr, up 56.89% YoY, while EBITDA grew 15.25% YoY to ₹2.04 Cr. PAT stood at ₹0.37 Cr, down 27.45% YoY due to higher finance costs (₹98.74 lakh) and incremental depreciation from recent expansions. Management guided for ~80% full-year FY27 revenue growth (~₹40.55 Cr). Receivables days improved significantly to ~251 days from ~397 days in FY26, with cash and equivalents at ₹12.78 Cr against borrowings of ₹23.16 Cr. Growth is driven by capacity ramp-ups and high-margin IVF expansion.

Original exchange filing (PDF)

More announcements from Aatmaj Healthcare Ltd

All Aatmaj Healthcare Ltd announcements